Combined treatment of CpG-oligodeoxynucleotide with Nutlin-3 induces strong immune stimulation coupled to cytotoxicity in B-chronic lymphocytic leukemic (B-CLL) cells (Q46903202)

From Wikidata

Jump to navigation Jump to search

scientific article published on 12 November 2007

Language	Label	Description	Also known as
English	Combined treatment of CpG-oligodeoxynucleotide with Nutlin-3 induces strong immune stimulation coupled to cytotoxicity in B-chronic lymphocytic leukemic (B-CLL) cells	scientific article published on 12 November 2007

Statements

scholarly article

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17998303

Combined treatment of CpG-oligodeoxynucleotide with Nutlin-3 induces strong immune stimulation coupled to cytotoxicity in B-chronic lymphocytic leukemic (B-CLL) cells (English)

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17998303

0 references

1 reference

based on heuristic

inferred from title

Paola Secchiero

1

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17998303

Mario Tiribelli

3

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17998303

Arianna Gonelli

4

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17998303

5

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17998303

Elisabetta Melloni

2

object named as

Elisabetta Melloni

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17998303

publication date

12 November 2007

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17998303

Journal of Leukocyte Biology

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17998303

83

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17998303

2

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17998303

434-437

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17998303

In vivo measurements document the dynamic cellular kinetics of chronic lymphocytic leukemia B cells

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0707459

21 January 2018

Differential Noxa/Mcl-1 balance in peripheral versus lymph node chronic lymphocytic leukemia cells correlates with survival capacity

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0707459

21 January 2018

Expression of cyclin E in resting and activated B-chronic lymphocytic leukaemia cells: cyclin E/cdk2 as a potential therapeutic target.

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0707459

21 January 2018

The Akt signaling pathway determines the different proliferative capacity of chronic lymphocytic leukemia B-cells from patients with progressive and stable disease.

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0707459

21 January 2018

Immunostimulatory oligodeoxynucleotides induce apoptosis of B cell chronic lymphocytic leukemia cells.

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0707459

21 January 2018

In vivo activation of the p53 pathway by small-molecule antagonists of MDM2

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0707459

21 January 2018

Functional integrity of the p53-mediated apoptotic pathway induced by the nongenotoxic agent nutlin-3 in B-cell chronic lymphocytic leukemia (B-CLL).

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0707459

21 January 2018

MDM2 antagonists activate p53 and synergize with genotoxic drugs in B-cell chronic lymphocytic leukemia cells.

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0707459

21 January 2018

ZAP-70 enhances B-cell-receptor signaling despite absent or inefficient tyrosine kinase activation in chronic lymphocytic leukemia and lymphoma B cells.

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0707459

21 January 2018

Characterization of three CpG oligodeoxynucleotide classes with distinct immunostimulatory activities.

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0707459

21 January 2018

Induction of the TRAIL receptor KILLER/DR5 in p53-dependent apoptosis but not growth arrest

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0707459

21 January 2018

Purine analogue-based chemotherapy regimens for patients with previously untreated B-chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0707459

21 January 2018

Fas-ligand (CD178) and TRAIL synergistically induce apoptosis of CD40-activated chronic lymphocytic leukemia B cells

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0707459

21 January 2018

Survivin is expressed on CD40 stimulation and interfaces proliferation and apoptosis in B-cell chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0707459

21 January 2018

Antiangiogenic Activity of the MDM2 Antagonist Nutlin-3

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0707459

21 January 2018

Differential gene expression induction by TRAIL in B chronic lymphocytic leukemia (B-CLL) cells showing high versus low levels of Zap-70

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0707459

21 January 2018

Identifiers

10.1189/JLB.0707459

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17998303

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17998303

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46903202&oldid=2137412417"